Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL)

INTRODUCTION: Recently, inhibition of programmed cell death 1 or its ligand has shown therapeutic effects on non-small cell lung cancer (NSCLC). However, the effectiveness of preoperative nivolumab monotherapy for stage I NSCLC remains unknown. The present study aimed to investigate the pathological...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Kagimoto, Atsushi, Tsutani, Yasuhiro, Mimae, Takahiro, Miyata, Yoshihiro, Ikeda, Norihiko, Ito, Hiroyuki, Maniwa, Yoshimasa, Suzuki, Kenji, Tsuboi, Masahiro, Yoshimura, Kenichi, Umemoto, Seiji, Okada, Morihito
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2021
Matèries:
Surgery
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7978092/
https://ncbi.nlm.nih.gov/pubmed/33737428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-043234
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars